Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 543 entries
Sorted by: Best Match Show Resources per page
Post-stroke emotional incontinence or bipolar disorder?.

Neuropsychiatric disease and treatment

Mnif L, Sellami R, Masmoudi J.
PMID: 27536109
Neuropsychiatr Dis Treat. 2016 Jul 29;12:1883-5. doi: 10.2147/NDT.S102273. eCollection 2016.

INTRODUCTION: Post-stroke emotional incontinence and bipolar disorder are two disorders that involve the dysfunction of brain structures responsible for emotional regulation. The objective of this work is to study the links between these disorders through a clinical case.CASE REPORT:...

Cite
Mnif L, Sellami R, Masmoudi J. Post-stroke emotional incontinence or bipolar disorder?. Neuropsychiatr Dis Treat. 2016;12:1883-5doi: 10.2147/NDT.S102273.
Mnif, L., Sellami, R., & Masmoudi, J. (2016). Post-stroke emotional incontinence or bipolar disorder?. Neuropsychiatric disease and treatment, 121883-5. https://doi.org/10.2147/NDT.S102273
Mnif, Leila, et al. "Post-stroke emotional incontinence or bipolar disorder?." Neuropsychiatric disease and treatment vol. 12 (2016): 1883-5. doi: https://doi.org/10.2147/NDT.S102273
Mnif L, Sellami R, Masmoudi J. Post-stroke emotional incontinence or bipolar disorder?. Neuropsychiatr Dis Treat. 2016 Jul 29;12:1883-5. doi: 10.2147/NDT.S102273. eCollection 2016. PMID: 27536109; PMCID: PMC4973722.
Copy Download .nbib Format: NLM
Treatment of major depressive disorders with generic duloxetine and paroxetine: a multi-centered, double-blind, double-dummy, randomized controlled clinical trial.

Shanghai archives of psychiatry

Wang Z, Xu X, Tan Q, Li K, Ma C, Xie S, Gao C, Wang G, Li H.
PMID: 26549959
Shanghai Arch Psychiatry. 2015 Aug 25;27(4):228-36. doi: 10.11919/j.issn.1002-0829.215064.

BACKGROUND: This study is a pre-registration trial of generic duloxetine that was approved by the China Food and Drug Administration (approval number: 2006L01603).AIMS: Compare the treatment efficacy and safety of generic duloxetine to that of paroxetine in patients with...

Cite
Wang Z, Xu X, Tan Q, et al. Treatment of major depressive disorders with generic duloxetine and paroxetine: a multi-centered, double-blind, double-dummy, randomized controlled clinical trial. Shanghai Arch Psychiatry. 2015;27(4):228-36doi: 10.11919/j.issn.1002-0829.215064.
Wang, Z., Xu, X., Tan, Q., Li, K., Ma, C., Xie, S., Gao, C., Wang, G., & Li, H. (2015). Treatment of major depressive disorders with generic duloxetine and paroxetine: a multi-centered, double-blind, double-dummy, randomized controlled clinical trial. Shanghai archives of psychiatry, 27(4), 228-36. https://doi.org/10.11919/j.issn.1002-0829.215064
Wang, Zhiyang, et al. "Treatment of major depressive disorders with generic duloxetine and paroxetine: a multi-centered, double-blind, double-dummy, randomized controlled clinical trial." Shanghai archives of psychiatry vol. 27,4 (2015): 228-36. doi: https://doi.org/10.11919/j.issn.1002-0829.215064
Wang Z, Xu X, Tan Q, Li K, Ma C, Xie S, Gao C, Wang G, Li H. Treatment of major depressive disorders with generic duloxetine and paroxetine: a multi-centered, double-blind, double-dummy, randomized controlled clinical trial. Shanghai Arch Psychiatry. 2015 Aug 25;27(4):228-36. doi: 10.11919/j.issn.1002-0829.215064. PMID: 26549959; PMCID: PMC4621288.
Copy Download .nbib Format: NLM
Stopping Antidepressants and Anxiolytics as Major Concerns Reported in Online Health Communities: A Text Mining Approach.

JMIR mental health

Abbe A, Falissard B.
PMID: 29061554
JMIR Ment Health. 2017 Oct 23;4(4):e48. doi: 10.2196/mental.7797.

BACKGROUND: Internet is a particularly dynamic way to quickly capture the perceptions of a population in real time. Complementary to traditional face-to-face communication, online social networks help patients to improve self-esteem and self-help.OBJECTIVE: The aim of this study was...

Cite
Abbe A, Falissard B. Stopping Antidepressants and Anxiolytics as Major Concerns Reported in Online Health Communities: A Text Mining Approach. JMIR Ment Health. 2017;4(4):e48doi: 10.2196/mental.7797.
Abbe, A., & Falissard, B. (2017). Stopping Antidepressants and Anxiolytics as Major Concerns Reported in Online Health Communities: A Text Mining Approach. JMIR mental health, 4(4), e48. https://doi.org/10.2196/mental.7797
Abbe, Adeline, and Falissard, Bruno. "Stopping Antidepressants and Anxiolytics as Major Concerns Reported in Online Health Communities: A Text Mining Approach." JMIR mental health vol. 4,4 (2017): e48. doi: https://doi.org/10.2196/mental.7797
Abbe A, Falissard B. Stopping Antidepressants and Anxiolytics as Major Concerns Reported in Online Health Communities: A Text Mining Approach. JMIR Ment Health. 2017 Oct 23;4(4):e48. doi: 10.2196/mental.7797. PMID: 29061554; PMCID: PMC5673886.
Copy Download .nbib Format: NLM
Korean Guidelines for the Pharmacological Treatment of Social Anxiety Disorder: Initial Treatment Strategies.

Psychiatry investigation

Yoon H, Oh DJ, Suh HS, Lee KU, Lim SW, Lee JY, Yang JC, Lee JH, Ha J, Lee BH, Kang SG, Yoon HK, Moon J, Bae SM, Kwon Y, Kim HC, Oh KS.
PMID: 29475215
Psychiatry Investig. 2018 Feb;15(2):147-155. doi: 10.30773/pi.2017.05.01. Epub 2017 Nov 29.

OBJECTIVE: The aim of the present study was to provide clinical consensus and evidence regarding initial treatment strategies for the pharmacological treatment of social anxiety disorder (SAD) in Korea.METHODS: We prepared a questionnaire to derive a consensus from clinicians...

Cite
Yoon H, Oh DJ, Suh HS, et al. Korean Guidelines for the Pharmacological Treatment of Social Anxiety Disorder: Initial Treatment Strategies. Psychiatry Investig. 2017;15(2):147-155doi: 10.30773/pi.2017.05.01.
Yoon, H., Oh, D. J., Suh, H. S., Lee, K. U., Lim, S. W., Lee, J. Y., Yang, J. C., Lee, J. H., Ha, J., Lee, B. H., Kang, S. G., Yoon, H. K., Moon, J., Bae, S. M., Kwon, Y., Kim, H. C., & Oh, K. S. (2018). Korean Guidelines for the Pharmacological Treatment of Social Anxiety Disorder: Initial Treatment Strategies. Psychiatry investigation, 15(2), 147-155. https://doi.org/10.30773/pi.2017.05.01
Yoon, Hyungkun, et al. "Korean Guidelines for the Pharmacological Treatment of Social Anxiety Disorder: Initial Treatment Strategies." Psychiatry investigation vol. 15,2 (2018): 147-155. doi: https://doi.org/10.30773/pi.2017.05.01
Yoon H, Oh DJ, Suh HS, Lee KU, Lim SW, Lee JY, Yang JC, Lee JH, Ha J, Lee BH, Kang SG, Yoon HK, Moon J, Bae SM, Kwon Y, Kim HC, Oh KS. Korean Guidelines for the Pharmacological Treatment of Social Anxiety Disorder: Initial Treatment Strategies. Psychiatry Investig. 2018 Feb;15(2):147-155. doi: 10.30773/pi.2017.05.01. Epub 2017 Nov 29. PMID: 29475215; PMCID: PMC5900408.
Copy Download .nbib Format: NLM
Paroxetine versus amitriptyline in patients with recurrent major depression: A double-blind trial.

International journal of psychiatry in clinical practice

Sacchetti E, Cassano GB, Penati G, Pavan L, Nardini M, Casacchia M, Pancheri P, Muscettola G, Faravelli C, Aguglia E, Nivoli G, Ravizza L, Castrogiovanni P.
PMID: 24931886
Int J Psychiatry Clin Pract. 2002;6(1):23-9. doi: 10.1080/136515002753489380.

INTRODUCTION: Long-term exposure to antidepressants is required to prevent relapses and recurrences in patients with recurrent major depression. Furthermore, a good pharmacological compliance is the key to successful long-term treatment. Since the early phases of a treatment influence long-term...

Cite
Sacchetti E, Cassano GB, Penati G, et al. Paroxetine versus amitriptyline in patients with recurrent major depression: A double-blind trial. Int J Psychiatry Clin Pract. 2002;6(1):23-9doi: 10.1080/136515002753489380.
Sacchetti, E., Cassano, G. B., Penati, G., Pavan, L., Nardini, M., Casacchia, M., Pancheri, P., Muscettola, G., Faravelli, C., Aguglia, E., Nivoli, G., Ravizza, L., & Castrogiovanni, P. (2002). Paroxetine versus amitriptyline in patients with recurrent major depression: A double-blind trial. International journal of psychiatry in clinical practice, 6(1), 23-9. https://doi.org/10.1080/136515002753489380
Sacchetti, Emilio, et al. "Paroxetine versus amitriptyline in patients with recurrent major depression: A double-blind trial." International journal of psychiatry in clinical practice vol. 6,1 (2002): 23-9. doi: https://doi.org/10.1080/136515002753489380
Sacchetti E, Cassano GB, Penati G, Pavan L, Nardini M, Casacchia M, Pancheri P, Muscettola G, Faravelli C, Aguglia E, Nivoli G, Ravizza L, Castrogiovanni P. Paroxetine versus amitriptyline in patients with recurrent major depression: A double-blind trial. Int J Psychiatry Clin Pract. 2002;6(1):23-9. doi: 10.1080/136515002753489380. PMID: 24931886.
Copy Download .nbib Format: NLM
Paroxetine-induced galactorrhea.

Indian journal of psychiatry

Gulati P, Chavan BS, Das S.
PMID: 25568484
Indian J Psychiatry. 2014 Oct;56(4):393-4. doi: 10.4103/0019-5545.146529.

Drug-induced galactorrhea has been reported with agents such as antidopaminergic antiemetics, antipsychotics, etc., with few case reports of galactorrhea with selective serotonin reuptake inhibitors, including paroxetine, being reported in last few decades. Prolactin levels have been found to be...

Cite
Gulati P, Chavan BS, Das S. Paroxetine-induced galactorrhea. Indian J Psychiatry. 2014;56(4):393-4doi: 10.4103/0019-5545.146529.
Gulati, P., Chavan, B. S., & Das, S. (2014). Paroxetine-induced galactorrhea. Indian journal of psychiatry, 56(4), 393-4. https://doi.org/10.4103/0019-5545.146529
Gulati, Prannay, et al. "Paroxetine-induced galactorrhea." Indian journal of psychiatry vol. 56,4 (2014): 393-4. doi: https://doi.org/10.4103/0019-5545.146529
Gulati P, Chavan BS, Das S. Paroxetine-induced galactorrhea. Indian J Psychiatry. 2014 Oct;56(4):393-4. doi: 10.4103/0019-5545.146529. PMID: 25568484; PMCID: PMC4279301.
Copy Download .nbib Format: NLM
Paroxetine alleviates rat limb post-ischemia induced allodynia through GRK2 upregulation in superior cervical ganglia.

International journal of clinical and experimental medicine

Tang J, Dong J, Yang L, Gao L, Zheng J.
PMID: 25932137
Int J Clin Exp Med. 2015 Feb 15;8(2):2065-76. eCollection 2015.

Long-lasting neuroplastic changes induced by transient decrease in G protein-coupled receptor kinase 2 (GRK2) in nociceptors enhances and prolongs inflammatory hyperalgesia. Here, we investigated the effects of paroxetine (a selective serotonin reuptake inhibitor and GRK2 inhibitor) on GRK2 expression...

Cite
Tang J, Dong J, Yang L, et al. Paroxetine alleviates rat limb post-ischemia induced allodynia through GRK2 upregulation in superior cervical ganglia. Int J Clin Exp Med. 2015;8(2):2065-76
Tang, J., Dong, J., Yang, L., Gao, L., & Zheng, J. (2015). Paroxetine alleviates rat limb post-ischemia induced allodynia through GRK2 upregulation in superior cervical ganglia. International journal of clinical and experimental medicine, 8(2), 2065-76.
Tang, Jun, et al. "Paroxetine alleviates rat limb post-ischemia induced allodynia through GRK2 upregulation in superior cervical ganglia." International journal of clinical and experimental medicine vol. 8,2 (2015): 2065-76.
Tang J, Dong J, Yang L, Gao L, Zheng J. Paroxetine alleviates rat limb post-ischemia induced allodynia through GRK2 upregulation in superior cervical ganglia. Int J Clin Exp Med. 2015 Feb 15;8(2):2065-76. eCollection 2015. PMID: 25932137; PMCID: PMC4402784.
Copy Download .nbib Format: NLM
Aldosterone Signals the Onset of Depressive Behaviour in a Female Rat Model of Depression along with SSRI Treatment Resistance.

Neuroendocrinology

Franklin M, Hlavacova N, Babic S, Pokusa M, Bermudez I, Jezova D.
PMID: 25968351
Neuroendocrinology. 2015;102(4):274-287. doi: 10.1159/000431152. Epub 2015 May 09.

Depression is a serious condition that occurs more frequently in women and is often associated with treatment resistance. The main hypotheses of this study are that (a) aldosterone is an early marker of depression onset and (b) a tryptophan...

Cite
Franklin M, Hlavacova N, Babic S, et al. Aldosterone Signals the Onset of Depressive Behaviour in a Female Rat Model of Depression along with SSRI Treatment Resistance. Neuroendocrinology. 2015;102(4):274-287doi: 10.1159/000431152.
Franklin, M., Hlavacova, N., Babic, S., Pokusa, M., Bermudez, I., & Jezova, D. (2015). Aldosterone Signals the Onset of Depressive Behaviour in a Female Rat Model of Depression along with SSRI Treatment Resistance. Neuroendocrinology, 102(4), 274-287. https://doi.org/10.1159/000431152
Franklin, Michael, et al. "Aldosterone Signals the Onset of Depressive Behaviour in a Female Rat Model of Depression along with SSRI Treatment Resistance." Neuroendocrinology vol. 102,4 (2015): 274-287. doi: https://doi.org/10.1159/000431152
Franklin M, Hlavacova N, Babic S, Pokusa M, Bermudez I, Jezova D. Aldosterone Signals the Onset of Depressive Behaviour in a Female Rat Model of Depression along with SSRI Treatment Resistance. Neuroendocrinology. 2015;102(4):274-287. doi: 10.1159/000431152. Epub 2015 May 09. PMID: 25968351.
Copy Download .nbib Format: NLM
Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Ram D, Patil S, Gowdappa B, Rajalakshmi I.
PMID: 26598594
Clin Psychopharmacol Neurosci. 2015 Dec 31;13(3):321-3. doi: 10.9758/cpn.2015.13.3.321.

Atomoxetine, a selective norepinephrine inhibitor, is effective in comorbid anxiety and attention deficit hyperactivity disorder, however its role in panic disorder is unknown. We are presenting a case of panic disorder, who initially partially responded to clonazepam. When clonazepam...

Cite
Ram D, Patil S, Gowdappa B, et al. Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report. Clin Psychopharmacol Neurosci. 2015;13(3):321-3doi: 10.9758/cpn.2015.13.3.321.
Ram, D., Patil, S., Gowdappa, B., & Rajalakshmi, I. (2015). Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 13(3), 321-3. https://doi.org/10.9758/cpn.2015.13.3.321
Ram, Dushad, et al. "Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report." Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol. 13,3 (2015): 321-3. doi: https://doi.org/10.9758/cpn.2015.13.3.321
Ram D, Patil S, Gowdappa B, Rajalakshmi I. Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report. Clin Psychopharmacol Neurosci. 2015 Dec 31;13(3):321-3. doi: 10.9758/cpn.2015.13.3.321. PMID: 26598594; PMCID: PMC4662177.
Copy Download .nbib Format: NLM
Elevated plasma paroxetine concentrations in a patient treated with a combination of paroxetine and pindolol.

International journal of psychiatry in clinical practice

Olver JS, Burrows GD.
PMID: 24940982
Int J Psychiatry Clin Pract. 1998;2(3):225-7. doi: 10.3109/13651509809115361.

Paroxetine and pindolol have been used in combination to augment the antidepressant response of SSEIs. The rationale given involves the prevention of a negative feedback inhibition of serotonergic neurons but few studies have addressed potential pharmacokinetic interactions. This paper...

Cite
Olver JS, Burrows GD. Elevated plasma paroxetine concentrations in a patient treated with a combination of paroxetine and pindolol. Int J Psychiatry Clin Pract. 1998;2(3):225-7doi: 10.3109/13651509809115361.
Olver, J. S., & Burrows, G. D. (1998). Elevated plasma paroxetine concentrations in a patient treated with a combination of paroxetine and pindolol. International journal of psychiatry in clinical practice, 2(3), 225-7. https://doi.org/10.3109/13651509809115361
Olver, J S, and Burrows, G D. "Elevated plasma paroxetine concentrations in a patient treated with a combination of paroxetine and pindolol." International journal of psychiatry in clinical practice vol. 2,3 (1998): 225-7. doi: https://doi.org/10.3109/13651509809115361
Olver JS, Burrows GD. Elevated plasma paroxetine concentrations in a patient treated with a combination of paroxetine and pindolol. Int J Psychiatry Clin Pract. 1998;2(3):225-7. doi: 10.3109/13651509809115361. PMID: 24940982.
Copy Download .nbib Format: NLM
Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the Treatment of Premature Ejaculation.

Nephro-urology monthly

Moudi E, Kasaeeyan AA.
PMID: 26981497
Nephrourol Mon. 2016 Jan 27;8(1):e32286. doi: 10.5812/numonthly.32286. eCollection 2016 Jan.

BACKGROUND: Several recent studies have investigated the therapeutic role of phosphodiesterase type 5 (PDE5) inhibitors in premature ejaculation (PE) used in the treatment of erectile dysfunction.OBJECTIVES: In the present research, the efficacy of paroxetine alone and paroxetine plus tadalafil...

Cite
Moudi E, Kasaeeyan AA. Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the Treatment of Premature Ejaculation. Nephrourol Mon. 2016;8(1):e32286doi: 10.5812/numonthly.32286.
Moudi, E., & Kasaeeyan, A. A. (2016). Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the Treatment of Premature Ejaculation. Nephro-urology monthly, 8(1), e32286. https://doi.org/10.5812/numonthly.32286
Moudi, Emadouddin, and Kasaeeyan, Ali Akbar. "Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the Treatment of Premature Ejaculation." Nephro-urology monthly vol. 8,1 (2016): e32286. doi: https://doi.org/10.5812/numonthly.32286
Moudi E, Kasaeeyan AA. Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the Treatment of Premature Ejaculation. Nephrourol Mon. 2016 Jan 27;8(1):e32286. doi: 10.5812/numonthly.32286. eCollection 2016 Jan. PMID: 26981497; PMCID: PMC4780280.
Copy Download .nbib Format: NLM
Activity of mitochondrial respiratory chain is increased by chronic administration of antidepressants.

Acta neuropsychiatrica

Scaini G, Maggi DD, De-Nês BT, Gonçalves CL, Ferreira GK, Teodorak BP, Bez GD, Ferreira GC, Schuck PF, Quevedo J, Streck EL.
PMID: 26952897
Acta Neuropsychiatr. 2011 Jun;23(3):112-8. doi: 10.1111/j.1601-5215.2011.00548.x.

OBJECTIVE: Depressive disorders, including major depression, are serious and disabling for affected patients. Although the neurobiological understanding of major depressive disorder focuses mainly on the monoamine hypothesis, the exact pathophysiology of depression is not fully understood.METHODS: Animals received daily...

Cite
Scaini G, Maggi DD, De-Nês BT, et al. Activity of mitochondrial respiratory chain is increased by chronic administration of antidepressants. Acta Neuropsychiatr. 2011;23(3):112-8doi: 10.1111/j.1601-5215.2011.00548.x.
Scaini, G., Maggi, D. D., De-Nês, B. T., Gonçalves, C. L., Ferreira, G. K., Teodorak, B. P., Bez, G. D., Ferreira, G. C., Schuck, P. F., Quevedo, J., & Streck, E. L. (2011). Activity of mitochondrial respiratory chain is increased by chronic administration of antidepressants. Acta neuropsychiatrica, 23(3), 112-8. https://doi.org/10.1111/j.1601-5215.2011.00548.x
Scaini, Giselli, et al. "Activity of mitochondrial respiratory chain is increased by chronic administration of antidepressants." Acta neuropsychiatrica vol. 23,3 (2011): 112-8. doi: https://doi.org/10.1111/j.1601-5215.2011.00548.x
Scaini G, Maggi DD, De-Nês BT, Gonçalves CL, Ferreira GK, Teodorak BP, Bez GD, Ferreira GC, Schuck PF, Quevedo J, Streck EL. Activity of mitochondrial respiratory chain is increased by chronic administration of antidepressants. Acta Neuropsychiatr. 2011 Jun;23(3):112-8. doi: 10.1111/j.1601-5215.2011.00548.x. PMID: 26952897.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 543 entries